Dr. Reddy’s Laboratories (DRREDDY) Share Price Falls 2.14% Today as Large Cap Pharma Stock Weakens
- September 30, 2026
- Posted by: Kunal Singla
- Category: News
Dr. Reddy’s Laboratories Share Price fell to Rs 1,213.15, down 2.14% from the previous close, while the company’s market capitalisation stood at Rs 1,02,707.41 crore. The move makes Dr. Reddy’s Laboratories Share Price one of the more closely read market updates in the healthcare space today, especially because the stock is a Large Cap name in Pharmaceuticals & Drugs. The price move is confirmed in Univest data; a company-specific reason has not been established. As a result, Dr. Reddy’s Laboratories Share Price Today is best read through the intraday price action, the company’s valuation profile and its place in the healthcare peer set. Univest is tracking the move alongside Dr. Reddy’s Laboratories Stock News and broader pharma market cues.
For readers looking at Dr. Reddy’s Laboratories Share Price Today, the stock is being watched not for a storyline built on speculation, but for what the numbers show. Dr. Reddy’s Laboratories Share Price is trading lower after an intraday range that stayed tight relative to the day’s gap from the previous close. That makes the share price fall relevant for stock analysis, fundamental analysis and sector analysis, particularly when compared with listed peers in the same industry. Univest data helps place the decline in context without assuming a trigger. Dr. Reddy’s Laboratories Share Price therefore remains a factual price-action event first, and a valuation and peer-comparison story second.
Dr. Reddy's Laboratories (DRREDDY) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,213.15 |
| Previous Close | Rs 1,239.65 |
| Today's Move | -Rs 26.50 (-2.14%) |
| Open | Rs 1,237.35 |
| High | Rs 1,237.35 |
| Low | Rs 1,212 |
| Market Capitalisation | Rs 1,02,707.41 crore |
| Market Cap Category | Large Cap |
Dr. Reddy’s Laboratories Share Price Today started at Rs 1,237.35, matched the day’s high at Rs 1,237.35 and later touched a low of Rs 1,212. At the time of reporting, Dr. Reddy’s Laboratories Share Price was Rs 1,213.15, compared with the previous close of Rs 1,239.65. That means the stock was down Rs 26.50, or 2.14%, in the latest session. The move is a clear share price fall, but the opening level and the day’s low show that the stock stayed close to its lower intraday zone rather than recovering meaningfully. With market capitalisation at Rs 1,02,707.41 crore, Dr. Reddy’s Laboratories Share Price remains a Large Cap market event, not a small swing in a thinly valued name. For investors tracking Dr. Reddy’s Laboratories Share Price Live, the key point today is the gap from the previous close and the fact that the stock did not move beyond the opening high. That is the core of Dr. Reddy’s Laboratories Stock Performance so far, and it sets up the fundamental view that follows.
Dr. Reddy's Laboratories (DRREDDY) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,02,707.41 crore |
| P/E Ratio | 32.11x |
| P/B Ratio | 2.71x |
| ROE | 11.69% |
| ROCE | 13.75% |
| EPS | Rs 38.6 |
| Book Value Per Share | Rs 457.39 |
| Dividend Yield | 0.65% |
Dr. Reddy's Laboratories (DRREDDY) fundamental metrics show P/E 32.11x, P/B 2.71x, ROE 11.69%, ROCE 13.75%. These ratios show where the company stands today and are not a call to buy or sell.
Dr. Reddy’s Laboratories has a market capitalisation of Rs 1,02,707.41 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 32.11x, P/B at 2.71x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.69% and ROCE of 13.75%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 38.6, book value per share of Rs 457.39, dividend yield of 0.65%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.72x, median ROE of 11.61%, median ROCE of 13.46%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 32.11x |
| Benchmark Median P/E | 31.72x |
| Benchmark Average P/E | 46.74x |
| Benchmark P/E Range | 3.11x to 663.29x |
| Company P/B Ratio | 2.71x |
| Benchmark Median P/B | 2.91x |
| Benchmark Average P/B | 4.27x |
| Company ROE | 11.69% |
| Benchmark Median ROE | 11.61% |
| Benchmark Average ROE | 10.59% |
| Company ROCE | 13.75% |
| Benchmark Median ROCE | 13.46% |
| Benchmark Average ROCE | 13.35% |
| Company Market Capitalisation | Rs 1,02,707.41 crore |
| Benchmark Median Market Cap | Rs 821.94 crore |
| Benchmark Average Market Cap | Rs 13,782.64 crore |
Dr. Reddy's Laboratories (DRREDDY) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Dr. Reddy's Laboratories (DRREDDY) has a P/E ratio of 32.11x, which is above the benchmark median of 31.72x, a difference of +1.23%. A P/E difference of this kind is a reference point rather than a recommendation.
Dr. Reddy's Laboratories (DRREDDY) has a ROE of 11.69%, which is above the benchmark median of 11.61%, a difference of +0.69%. Dr. Reddy's Laboratories (DRREDDY) has a ROCE of 13.75%, which is above the benchmark median of 13.46%, a difference of +2.15%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,22,067.01 | 35.09 | 4.91 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,48,982.98 | 84.18 | 13.94 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,77,974.12 | 80.83 | 19.64 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,13,615.69 | 25 | 4.18 | 19.69 | 21.39 |
| Laurus Labs | LAURUSLABS | 1,11,898.66 | 101.36 | 19.65 | 18.31 | 18.2 |
Dr. Reddy's Laboratories (DRREDDY) has a P/E ratio of 32.11x compared with the displayed peer median of 80.83x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.69% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 13.75% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Dr. Reddy's Laboratories (DRREDDY) has a market capitalisation of Rs 1,02,707.41 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Dr. Reddy’s Laboratories
- Dr. Reddy’s Laboratories Share Price fell 2.14% to Rs 1,213.15, so the intraday move is immediately visible in market screens.
- The company is a Large Cap healthcare name, which makes Dr. Reddy’s Laboratories Share Price a meaningful move within the pharma universe.
- P/E of 32.11 and P/B of 2.71 keep Dr. Reddy’s Laboratories Share Price in the valuation comparison set for the same industry.
- ROE of 11.69% and ROCE of 13.75% place the stock near the middle of the sector benchmark on returns.
- Peer comparisons against Sun Pharmaceutical Industries, Cipla and Zydus Lifesciences help frame Dr. Reddy’s Laboratories Share Price in context.
About Dr. Reddy’s Laboratories
Dr. Reddy’s Laboratories operates in Pharmaceuticals & Drugs within the Healthcare sector. The company is known for developing, manufacturing and marketing pharmaceutical products across key therapy areas and market segments. Dr. Reddy’s Laboratories Share Price reflects the market’s view of a large, established pharma business with a broad operating footprint. In the context of Dr. Reddy’s Laboratories Stock News, the company is a core listed name rather than a niche specialist, and that scale is part of why the stock often features in market updates. Univest tracks the company as a Large Cap healthcare stock within the broader Indian pharmaceutical universe.
Track Dr. Reddy’s Laboratories Share Price on Univest
Use Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Users can follow Dr. Reddy’s Laboratories Share Price on Univest for live market moves, valuation ratios, market capitalisation, 52-week levels and sector comparisons. Univest also helps readers review Dr. Reddy’s Laboratories Fundamental Analysis, Dr. Reddy’s Laboratories Stock Analysis and the latest Dr. Reddy’s Laboratories Share Price News in one place. For investors scanning Dr. Reddy’s Laboratories Share Price Today, Univest keeps the focus on verified numbers, company context and peer benchmarking.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Dr. Reddy's Laboratories Share Price falling today?
Ans. Dr. Reddy's Laboratories Share Price fell 2.14% to Rs 1,213.15 from the previous close of Rs 1,239.65. The price move is confirmed in Univest data; a company-specific reason has not been established.
What is Dr. Reddy's Laboratories Share Price Today?
Ans. Dr. Reddy's Laboratories Share Price Today stood at Rs 1,213.15 at the reported time. The stock moved between Rs 1,212 and Rs 1,237.35 during the day, showing a narrow intraday range.
How much did Dr. Reddy's Laboratories Share Price decline?
Ans. Dr. Reddy's Laboratories Share Price declined by Rs 26.50, which equals 2.14% versus the previous close. That makes it a clear same-day price fall rather than a marginal move. The previous close was Rs 1,239.65.
What is the market capitalisation of Dr. Reddy's Laboratories?
Ans. Dr. Reddy's Laboratories has a market capitalisation of Rs 1,02,707.41 crore. This places it in the Large Cap category and keeps Dr. Reddy's Laboratories Share Price relevant in the healthcare sector.
Is Dr. Reddy's Laboratories Share Price expensive versus peers?
Ans. Dr. Reddy's Laboratories Share Price is around the middle of the same-industry range. Its P/E is below some richer peers such as Divi's Laboratories and Torrent Pharmaceuticals, but above Zydus Lifesciences and Aurobindo Pharma
How does Dr. Reddy's Laboratories compare with the sector benchmark?
Ans. Dr. Reddy's Laboratories has a P/E of 32.11 versus the sector median of 31.72 and a P/B of 2.71 versus the sector median of 2.91. ROE and ROCE are also slightly above the sector medians.
What is the dividend yield in Dr. Reddy's Laboratories Share Price data?
Ans. Dr. Reddy's Laboratories Share Price data shows a dividend yield of 0.65%. That is a modest historical payout reference and should be read alongside valuation, earnings and book value per share.
Should investors track Dr. Reddy's Laboratories Share Price on Univest?
Ans. Yes, because Univest tracks Dr. Reddy's Laboratories Share Price with price action, valuation ratios, market capitalisation and peer context. It is useful for following Dr. Reddy's Laboratories Stock News and sector comparison in one place.
